Downregulation of the tyrosine degradation pathway extends lifespan.
Title | Downregulation of the tyrosine degradation pathway extends lifespan. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Parkhitko AA, Ramesh D, Wang L, Leshchiner D, Filine E, Binari R, Olsen AL, Asara JM, Cracan V, Rabinowitz JD, Brockmann A, Perrimon N |
Journal | Elife |
Volume | 9 |
Date Published | 2020 Dec 15 |
ISSN | 2050-084X |
Abstract | Aging is characterized by extensive metabolic reprogramming. To identify metabolic pathways associated with aging, we analyzed age-dependent changes in the metabolomes of long-lived . Among the metabolites that changed, levels of tyrosine were increased with age in long-lived flies. We demonstrate that the levels of enzymes in the tyrosine degradation pathway increase with age in wild-type flies. Whole-body and neuronal-specific downregulation of enzymes in the tyrosine degradation pathway significantly extends lifespan, causes alterations of metabolites associated with increased lifespan, and upregulates the levels of tyrosine-derived neuromediators. Moreover, feeding wild-type flies with tyrosine increased their lifespan. Mechanistically, we show that suppression of ETC complex I drives the upregulation of enzymes in the tyrosine degradation pathway, an effect that can be rescued by tigecycline, an FDA-approved drug that specifically suppresses mitochondrial translation. In addition, tyrosine supplementation partially rescued lifespan of flies with ETC complex I suppression. Altogether, our study highlights the tyrosine degradation pathway as a regulator of longevity. |
DOI | 10.7554/eLife.58053 |
Alternate Journal | Elife |
PubMed ID | 33319750 |
Grant List | K99/R00 AG057792 / AG / NIA NIH HHS / United States 5P01CA120964 / GF / NIH HHS / United States |